...
首页> 外文期刊>BMC Medicine >Incidence, detection, and tumour stage of breast cancer in a cohort of Italian women with negative screening mammography report recommending early (short-interval) rescreen
【24h】

Incidence, detection, and tumour stage of breast cancer in a cohort of Italian women with negative screening mammography report recommending early (short-interval) rescreen

机译:一组乳腺癌筛查结果为阴性的意大利女性乳腺癌的发生率,发现和肿瘤分期,建议早期(短间隔)重新筛查

获取原文
           

摘要

Background Although poorly described in the literature, the practice of early (short-interval) rescreen after a negative screening mammogram is controversial due to its financial and psychological burden and because it is of no proven benefit. Methods The present study targeted an Italian 2-yearly screening programme (Emilia-Romagna Region, 1997-2002). An electronic dataset of 647,876 eligible negative mammography records from 376,257 women aged 50-69 years was record-linked with the regional breast cancer registry. The statistical analysis addressed the following research questions: (1) the prevalence of recommendation for early ( Results RES was used in eight out of 13 screening centres, where it was found in 4171 out of 313,320 negative reports (average rate 1.33%; range 0.05%-4.33%). Reports with RES were more likely for women aged 50-59 years versus older women (odds ratio (OR) 1.33; 95% CI 1.25-1.42), for the first versus subsequent screening rounds (OR 1.91; 95% CI 1.79-2.04) and with a centre-specific recall rate below the average of 6.2% (OR 1.41; 95% CI 1.32-1.50). RES predicted a 3.51-fold (95% CI 0.94-9.29) greater proportional incidence of first-year interval cancers, a 1.90-fold (95% CI 1.62-2.22) greater recall rate at the next screen, a 1.72-fold (95% CI 1.01-2.74) greater detection rate of cancer at the next screen and a non-significantly decreased risk of late disease stage (OR 0.59; 95% CI 0.23-1.53). Conclusion The prevalence of RES was in line with the maximum standard level established by the Italian national guidelines. RES identified a subset of women with greater incidence of interval cancers and greater prevalence of cancers detected at the next screen.
机译:背景技术尽管在文献中没有对此进行充分描述,但由于其财务和心理负担,并且没有经过证实的益处,因此在负乳腺钼靶筛查后进行早期(短间隔)重新筛查的做法引起争议。方法:本研究的目标是意大利一项为期2年的筛查计划(Emilia-Romagna Region,1997-2002)。电子数据集包含376,257名年龄在50-69岁之间的女性中的647,876例合格的X线摄影阴性记录,并与地区乳腺癌登记系统进行了记录关联。统计分析解决了以下研究问题:(1)早期推荐的普遍性(在13个筛查中心中有8个使用了结果RES,在313320例阴性报告中有4171例被发现(平均率为1.33%;范围为0.05) %-4.33%)。在第一轮筛查和随后的几轮筛查中,年龄在50-59岁之间的女性与年龄较大的女性相比(RES(OR)1.33; 95%CI 1.25-1.42)更有可能报道RES(OR 1.91; 95) %CI 1.79-2.04),且中心特定的召回率低于平均值6.2%(OR 1.41; 95%CI 1.32-1.50)。RES预测比例召回率高3.51倍(95%CI 0.94-9.29)。第一年间隔期癌症,在下一个筛查时的召回率高1.90倍(95%CI 1.62-2.22),在下一个筛查时的癌症检出率高1.72倍(95%CI 1.01-2.74) -疾病晚期的风险显着降低(OR 0.59; 95%CI 0.23-1.53​​)结论RES的患病率符合最大标准水平e受意大利国家准则的约束。 RES鉴定了一部分女性,在下一次筛查中发现的间隔癌的发生率更高,癌症的患病率更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号